Empty IV bags market seen growing to $12.51B by 2030

The global empty intravenous bag market is projected to rise from $7.15 billion in 2025 to $12.51 billion by 2030, driven by more surgeries, chronic disease care and demand for safer infusion packaging. North America led the market in 2025, while Asia-Pacific is expected to grow fastest through the forecast period.

Why it matters: - Empty intravenous bags are a core input for hospitals, clinics and infusion care. - The market’s growth points to rising demand for surgery support, chronic disease treatment and outpatient care. - The shift toward safer packaging materials could reshape supplier competition and product design.

What happened: - The empty intravenous bags market is projected to grow from $7.15 billion in 2025 to $8.08 billion in 2026. - The market is forecast to reach $12.51 billion by 2030. - The report puts the 2026-2030 growth rate at 11.6% CAGR. - North America held the largest market share in 2025. - Asia-Pacific is expected to be the fastest-growing region during the forecast period. - The report covers Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East and Africa. - The Business Research Company published the report, titled “Empty Intravenous (IV) Bags Market Report 2026 – Market Size, Trends, And Global Forecast 2026-2035.” - A free sample is available here. - The full report is available here.

The details: - Empty intravenous bags are sterile, flexible containers used to deliver fluids, medications or nutrients directly into a patient’s bloodstream. - The bags come in different sizes and materials and typically include ports for IV lines and infusion equipment. - The market’s near-term growth is tied to rising hospital admissions, greater use of IV therapies, healthcare expansion, more chronic illness and broader adoption of IV drug delivery methods. - Growth through 2030 is linked to stronger demand for infusion treatments, an aging population, more surgical and critical care procedures, more outpatient and clinic services and safer IV packaging materials. - Key trends include reduced use of PVC bags, more interest in multi-chamber designs, wider use in acute and critical care, ready-to-mix and customized IV solutions, and more focus on sterility and contamination control. - Surgery demand is a major driver because empty IV bags support fluids, medications, blood products and anesthesia during procedures. - The American Society of Plastic Surgeons reported a 5% rise in plastic surgeries and a 7% increase in minimally invasive procedures in 2023 versus 2022. - Chronic disease is another driver because empty IV bags are used for personalized medication delivery, home infusion, nutritional support, hydration and palliative care. - The CDC said in April 2025 that about 194 million U.S. adults, or 76.4%, had at least one chronic condition in 2023. - The CDC data showed chronic conditions affected 59.5% of young adults, 78.4% of midlife adults and 93.0% of older adults.

Between the lines: - The market outlook suggests suppliers are competing on materials, sterility and customization rather than basic bag volume alone. - The move away from PVC and toward multi-chamber or ready-to-mix formats signals demand for more specialized infusion products. - The regional split points to a mature North American market and faster expansion opportunities in Asia-Pacific.

What’s next: - Demand should track the pace of surgeries, chronic disease treatment and outpatient infusion growth. - Product innovation is likely to center on safer materials, contamination control and more flexible dosing formats. - The report says new 2026 editions include market attractiveness scoring, TAM analysis, company scoring matrix graphics, Excel-based forecasting dashboards, market hotspots infographics, key technology analysis and updated tables and graphics.

The bottom line: - Empty IV bags are moving from a steady medical supply category to a faster-growing market shaped by safety, customization and rising clinical demand.